Jenburkt Pharmaceuticals standalone net profit declines 16.02% in the March 2021 quarter

Sales decline 2.38% to Rs 29.56 crore

Net profit of Jenburkt Pharmaceuticals declined 16.02% to Rs 3.88 crore in the quarter ended March 2021 as against Rs 4.62 crore during the previous quarter ended March 2020. Sales declined 2.38% to Rs 29.56 crore in the quarter ended March 2021 as against Rs 30.28 crore during the previous quarter ended March 2020.

For the full year,net profit rose 10.96% to Rs 16.50 crore in the year ended March 2021 as against Rs 14.87 crore during the previous year ended March 2020. Sales declined 8.07% to Rs 109.29 crore in the year ended March 2021 as against Rs 118.89 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales29.5630.28 -2 109.29118.89 -8 OPM %17.0520.77 -18.1516.61 - PBDT6.187.46 -17 23.6823.44 1 PBT5.656.89 -18 21.6421.14 2 NP3.884.62 -16 16.5014.87 11

Powered by Capital Market - Live News